```json
{
"content": [
{
"type": "paragraph",
"content": "Drug of Abuse (DOA) Testing Equipment Market: A critical segment of healthcare and safety infrastructure, the DOA testing equipment market encompasses devices and systems used to identify illicit substances in biological samples. With rising concerns over opioid crises, workplace safety mandates, and regulatory compliance, the Drug of Abuse Testing Equipment market size is poised for strategic industry expansion. This report analyzes the growth outlook through 2033, leveraging 2025 as the base year and forecasting macroeconomic, technological, and policy-driven trends."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Point-of-Care Testing", "Laboratory Testing", "Mobile Testing Kits"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[1200, 1250, 1320, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2100, 2200, 2300], // Point-of-Care Testing
[800, 820, 850, 880, 900, 930, 960, 990, 1020, 1050, 1080, 1110, 1140], // Laboratory Testing
[400, 420, 440, 470, 500, 530, 560, 590, 620, 650, 680, 710, 740] // Mobile Testing Kits
]
}
},
{
"type": "paragraph",
"content": "The Drug of Abuse Testing Equipment market is projected to grow at a CAGR of 7.2% from 2026 to 2033, driven by advancements in rapid diagnostic technologies and stringent anti-doping regulations. Key macro drivers include the U.S. Department of Transportation’s drug testing mandates and Asia-Pacific’s urbanization-fueled demand. North America dominates the market due to established healthcare infrastructure, while Southeast Asia represents the fastest-growing region, spurred by rising illicit drug use and government-funded screening programs. The shift toward portable, AI-integrated testing devices and decentralized testing models underscores the industry’s technological evolution."
}
]
}
```
